CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
NCT Number: NCT02614638
The main objective of this study is to evaluate the impact of the presence of a pharmacy technician in a care unit (Hepato-Gastroenterology Department) on detected medication errors.
This is a before-after study consisting of three sequential phases:
Month 1: one month of observation of what is happening in the department Month 2: one month wash out period Month 3: active participation of a pharmacy technician in the department
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nîmes, 30029, France
The secondary objectives of this study are:
A- To assess the impact of the presence of a pharmacy technician on the ratio of the number of patients with at least one medication error / number of included patients hospitalized in the service.
B- To characterize detected medication errors.
C- To identify and evaluate the potential causes of medication errors.
D- To evaluate whether the presence of a pharmacy technician reduces nursing time spent on medication management.
E- To evaluate the economic impact of the presence of a pharmacy technician.
F- To evaluate the acceptability of the intervention by the nursing staff and pharmacy technicians using questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A pharmacy technician will be present full time in the care unit from Monday to Friday between 8:30 and 17h for 1 month for observational purposes only. During this phase, the pharmacy technician observes the current practices of preparation and administration of medication by nurses. He / she will collect medication errors and other observational data.
Following a 1 month wash-out period, a pharmacy technician will again be present full time (in practice, two technicians will relay each other) in the care unit from Monday to Friday between 8:30 and 17h for 1 month. He/she will actively take part in drug care activities in the department: management of product pathways, verification of injectable preparation, advice, etc. Medication errors and other observational data will be collected.
Time frame: 5 days
Primary Outcome Measure as given in protocol: Number of medication errors / number of medications administered and omitted from among all those listed on the prescription for admission (during month 1 versus during month 3).
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Errors are classifies as one of the following types:
Omission; Drug; Dosage form; Expired or damaged drug; Dose; Concentration; Frequency of administration; Administration technique; Route of Administration; Rate of administration; Duration of administration; Administration Time; Patient; Drug interaction.
Time frame: 5 days
Time frame: 5 days
The considered steps are:
Writing the prescription Medical decision for the prescription Transcription Pharmaceutical analysis Deliverance Preparation / reconstitution Pillbox Administration Procurement Storage Compliance Therapeutic and clinical follow-up
Time frame: 5 days
Time frame: 5 days
Criticality is graded according to the following classes:
3E: treatment or surgery with temporary harm 3F: longer duration of hospitalization with temporary harm 3G: permanent harm 3H: involving a life-threatening harm 3I: death
Criticality is determined by the concordance of two, independent expert opinions; or, in case of discordance, the concordance of 2 out 3 expert opinions.
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
Centre Hospitalier Universitaire de Nīmes
Other
Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy in the Hepato-Gastroenterology Department of the Nîmes University Hospital
Acronym: OPTI-PP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06570993
Aberrant Motor Behavior in Dementia, Aggression
Auckland, Niue
View Trial DetailsNCT07202962
Deprescribing, Elderly (People Aged 65 or More)
Santorso, Vicenza, Italy
View Trial DetailsNCT07156448
Activities of Daily Living, Aged 65 Years or Older
Taichung, Taichung City, Taiwan
View Trial DetailsNCT05694546
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Lusaka, Zambia
View Trial Details